Hypertensive crises. 1991

K B Keller, and L Lemberg
Department of Medicine, University of Miami School of Medicine, FL 33101.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004509 Education, Nursing, Continuing Educational programs designed to inform nurses of recent advances in their fields. Education, Nursing, Post-Basic,Education, Nursing, Post-Registration,Nursing Education, Continuing,Nursing Education, Post-Basic,Nursing Education, Post-Registration,Post-Basic Nursing Education,Post-Registration Nursing Education,Continuing Nursing Education,Education, Continuing Nursing,Education, Post-Basic Nursing,Education, Post-Registration Nursing,Nursing Education, Post Basic,Nursing Education, Post Registration,Post Basic Nursing Education,Post Registration Nursing Education
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

K B Keller, and L Lemberg
December 1999, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K B Keller, and L Lemberg
March 1983, Primary care,
K B Keller, and L Lemberg
August 1996, Ugeskrift for laeger,
K B Keller, and L Lemberg
November 1968, Klinicheskaia meditsina,
K B Keller, and L Lemberg
September 2008, Primary care,
K B Keller, and L Lemberg
June 1999, Current treatment options in cardiovascular medicine,
K B Keller, and L Lemberg
January 1998, Terapevticheskii arkhiv,
K B Keller, and L Lemberg
January 1984, Sovetskaia meditsina,
K B Keller, and L Lemberg
December 1995, Acta medica portuguesa,
K B Keller, and L Lemberg
February 1976, Klinicheskaia meditsina,
Copied contents to your clipboard!